Document 3J9eEezyZ0p6O5DJdwKMvY7VJ
Co
slil
ii
;!| Eo|
ER 5
226-~ 17/15
J
gd SEa3zTnEgp EiSipLia IiNNgElY
gH ss HEigR thHH
.7
BH sHie rEgfi Htil nAgb:iHiHd33
g|l g& theraatied
BHi| E lry|i a H cfaafiei plb slk iaiu e ifinreh iie
i ont Fiersyiiicid
| oE
sin Eth
! 2i
sf plha inn giang
i 1 Hapa fil ein
g| {1 E teEnLt
i =3$$osgasG i SSialr nliiiia ni tgshiif niigeiii it nHanhkHly
HE] Biociiniin
2:
f filerf s labi ios 5:}
Pinas 1 1 hin is spfiBpEiRsTsi8i8s2l2d8
:
3 : Hi3 dz -
P Pio o:
:i
:
|
||
||}
CANCER PREVALENCE IN SUBJECTS EXPOSED TO PERFLUOROOCTANONIC ACID (PFOA)
James DablgrenMD", Ayman B
Torabim MD'*', Raphael Warshaw',
Harpreet Takbar MPH'
tnstr
[ES
[----
= [mm |
|
I Results
a----
=
CL few|W]
ar--rramr--
EerH EE EE
Bie
~~
#E